Metraipolis › archive › dc_d82fdd39a48c

Comparison of 6 cycles with 4 cycles of chemotherapy and atezolizumab in the first-line treatment of ES-SCLC: a retrospective multicenter analysis — Europe PMC PMID:41838398

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41838398
DOI
10.1093/oncolo/oyag092
License (as archived)
solo-consultazione
Archived
2026-11-05T11:55:48.309Z
SHA-256 of the archived text
528a3d23559a37633a0d10d84c1b4250f1328054dce0847d07aafbf7ec0dd422
Stable URL of this page
https://metraipolis.com/documento/dc_d82fdd39a48c

How to cite

Comparison of 6 cycles with 4 cycles of chemotherapy and atezolizumab in the first-line treatment of ES-SCLC: a retrospective multicenter analysis — Europe PMC PMID:41838398 — Europe PMC (en), https://europepmc.org/article/MED/41838398 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d82fdd39a48c (Metraipolis archive dc_d82fdd39a48c, sha256 528a3d23559a37633a0d10d84c1b4250f1328054dce0847d07aafbf7ec0dd422)
BibTeX
@misc{dcd82fdd39a48c,
  title = {Comparison of 6 cycles with 4 cycles of chemotherapy and atezolizumab in the first-line treatment of ES-SCLC: a retrospective multicenter analysis — Europe PMC PMID:41838398},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41838398},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d82fdd39a48c; sha256 528a3d23559a37633a0d10d84c1b4250f1328054dce0847d07aafbf7ec0dd422},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41838398. Agents can read the archived copy with the MCP tool read_document.